<div id="readability-page-1"><p>683 Capital Management LLC grew its holdings in  MeiraGTx Holdings PLC (NASDAQ:MGTX - Free Report) by 4.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor  owned 2,690,000 shares of the company's stock after purchasing an additional 115,000 shares during the quarter. MeiraGTx makes up   1.2% of 683 Capital Management LLC's portfolio, making the stock its 14th biggest position. 683 Capital Management LLC owned 3.35% of MeiraGTx worth $17,539,000 as of its most recent SEC filing.</p><p>A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Adage Capital Partners GP L.L.C. increased its holdings in  MeiraGTx by 7.1% during the second quarter. Adage Capital Partners GP L.L.C. now owns 6,034,578 shares of the company's stock valued at $39,345,000 after buying an additional 400,000 shares during the period.  Erste Asset Management GmbH boosted its position in  MeiraGTx by 17.9% during the 1st quarter. Erste Asset Management GmbH now owns 789,702 shares of the company's stock valued at $5,366,000 after acquiring an additional 120,000 shares in the last quarter.  22NW LP purchased a new position in shares of  MeiraGTx in the 2nd quarter valued at $3,824,000.  Invesco Ltd. increased its holdings in shares of  MeiraGTx by 1,628.7% in the 1st quarter. Invesco Ltd. now owns 350,401 shares of the company's stock valued at $2,376,000 after acquiring an additional 330,131 shares during the period.  Finally, Long Focus Capital Management LLC raised its position in shares of  MeiraGTx by 31.6% in the 1st quarter. Long Focus Capital Management LLC now owns 249,745 shares of the company's stock worth $1,693,000 after acquiring an additional 60,000 shares in the last quarter. 67.48% of the stock is currently owned by institutional investors. </p><h2>Insider Transactions at MeiraGTx</h2><p>In other MeiraGTx news, CFO Richard Giroux sold 24,000 shares of the business's stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $8.87, for a total transaction of $212,880.00. Following the sale, the chief financial officer owned 829,494 shares in the company, valued at approximately $7,357,611.78. The trade was a 2.81% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, CEO Alexandria Forbes sold 47,500 shares of the stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $8.39, for a total value of $398,525.00. Following the completion of the transaction, the chief executive officer directly owned 1,313,983 shares in the company, valued at $11,024,317.37. This represents a 3.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own  7.50% of the company's stock. </p><h2>MeiraGTx Stock Up 2.3%</h2><p>NASDAQ:MGTX opened at $8.92 on Friday. The company has a current ratio of 0.22, a quick ratio of 0.22 and a debt-to-equity ratio of 26.29. MeiraGTx Holdings PLC has a twelve month low of $4.55 and a twelve month high of $9.73. The company has a market cap of $717.98 million, a PE ratio of -4.23 and a beta of 1.38. The company's 50 day moving average is $8.35 and its two-hundred day moving average is $7.75. </p><p>MeiraGTx (NASDAQ:MGTX - Get Free Report) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.50) by ($0.12). The company had revenue of $0.41 million for the quarter, compared to analyst estimates of $7.71 million. MeiraGTx had a negative return on equity of 1,065.47% and a negative net margin of 615.27%. Analysts anticipate that  MeiraGTx Holdings PLC will post -1.48 EPS for the current year. </p><h2>Wall Street Analysts Forecast Growth</h2><p>MGTX has been the topic of a number of recent research reports. Chardan Capital  reaffirmed a &#34;buy&#34; rating and set a $35.00 price objective on shares of MeiraGTx in a research report on Tuesday, November 11th. HC Wainwright began coverage on shares of MeiraGTx in a report on Monday, November 24th. They issued a &#34;buy&#34; rating and a $20.00 price target on the stock. Raymond James Financial assumed coverage on shares of MeiraGTx in a research report on Tuesday, October 21st. They issued a &#34;strong-buy&#34; rating and a $29.00 price objective on the stock. Wall Street Zen lowered shares of MeiraGTx from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, November 15th. Finally, Royal Bank Of Canada raised their target price on shares of MeiraGTx from $12.00 to $16.00 and gave the company an &#34;outperform&#34; rating in a research note on Friday, November 14th. One research analyst  has rated the stock with a Strong Buy rating, four have given a Buy rating and one  has given a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $26.00.</p><p><b>Read Our Latest Analysis on MeiraGTx</b></p><h2>MeiraGTx Profile</h2> (Free Report)<p>MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.</p><h2>See Also</h2><ul><li>Five stocks we like better than MeiraGTx</li><li>What Are the FAANG Stocks and Are They Good Investments?</li><li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li><li>Basic Materials Stocks Investing</li><li>The Best Holiday Present You Can Give Yourself? Costco Stock</li><li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li><li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUdUWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUdUWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in MeiraGTx Right Now?</h2><p>Before you consider MeiraGTx, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MeiraGTx wasn't on the list.</p><p>While MeiraGTx currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MGTX

<p>683 Capital Management LLC increased its holdings in MeiraGTx Holdings PLC by 4.5% in Q2, owning 2,690,000 shares worth $17.54 million. Other institutional investors also modified their holdings. MeiraGTx's stock rose 2.3%, with a market cap of $717.98 million. Recent insider transactions included sales by CFO Richard Giroux and CEO Alexandria Forbes. Analysts have mixed ratings on the stock, with some forecasting growth and others downgrading it.</p>

683 Capital Management LLC Boosts Stock Holdings in MeiraGTx Holdings PLC $MGTX